Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kesko updates its growth strategy – an investor event to be held later today will offer management views on the updates

The Board of Directors of Kesko Corporation has confirmed an updated strategy for the company. The main pillars will remain intact, while each division’s competitive advantages and objectives have been refined. Profitable growth in three selected divisions – grocery trade, building and technical trade, and car trade – remains at the core of Kesko’s growth strategy. In all businesses, Kesko seeks sales growth, a better customer experience, and profitability and efficiency with the help of e.g. digital services and artificial intelligence. ”Kesko has a good, effective strategy, and we

Repurchases of shares during week 22, 2024

Between 27 May and 31 May 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 192,934 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced on 24 April 2024. The repurchase program, which runs between 29 April 2024 and 18 July 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No

Faron commences a share offering

Faron Pharmaceuticals Ltd (“Faron” or the “Company”) Inside Information: Faron commences a share offering of preliminarily a maximum of 30,714,592 Offer Shares at a subscription price of EUR 1.00 per Offer Share and publishes a prospectus NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.   THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY

Receipt of Funds from Sipiem

4 June 2024   Quantum Blockchain Technologies Plc( “QBT” or “the Company”)     First Sipiem Settlement – Confirmation of receipt of funds   With reference to the Company’s earlier announcement dated 16 May 2024, the Board of Quantum Blockchain Technologies (AIM: QBT) is pleased to confirm that, with respect to the First Sipiem Settlement, the payment of €700,000 has now been completed.   The Company and CL17 also confirm that €170,000 has been paid to Sipiem’s Receiver to complete the acquisition by CL17 of the Receiver’s right to receive 30% of any further sums

The Seasonal Shift - Balancing Leisure Spending and Construction in the Summer Surge.

As the calendar turns to June, the construction industry navigates a unique seasonal shift. The warmth of summer traditionally beckons people outdoors, encouraging travel and leisure activities that were largely put on pause during the pandemic years. This change in consumer behaviour significantly impacted the construction sector, which saw a boom in home improvement and residential projects when travel was restricted. As the world embraces the joys of summer and the freedom to roam, construction companies and related industries find themselves at a crossroads, adapting to the dual demands

poLight ASA – continues to build confidence in future positive development

KEY EVENTS in the quarter · Action Prowave Technology confirmed release of two new barcode scanner products using TLens®. · PhenoSys released Turnkey Mini2P Systems with poLight ASA Tunable Optics. · Thorlabs released an Optical Cage System Product with Integrated TLens® at SPIE Photonics West 2024. · poLight showcased Tunable Optics Technology at SPIE Photonics West 2024. · At an Extraordinary General Meeting on 15 January 2024, Marianne Bøe (Head of Investor Relations at IDEX Biometrics) and Jean-Christophe Eloy (CEO and President of Yole) were elected as new board

Systemair AB, Year-end report 1 May 2023 – 30 April 2024

PRESS RELEASE, 4 JUNE 2024 Fourth quarter February – April 2024 · Net sales decreased 1.9 percent to SEK 3,069 million (3,129). · Organic growth was +1.0 percent (+13.0). · Operating profit totalled SEK 233 million (734) and the operating margin was 7.6 percent (23.5).  · Adjusted operating profit amounted to SEK 209 million (282) and the adjusted operating margin was 6.8 percent (8.9). The adjustments refer to a credit loss on accounts receivable in Norway of a total of SEK -5.4 million and a positive adjustment for hyperinflation calculation of SEK +29.8 million. ·

Capsol Technologies ASA: Application deadline for applicants using Nordnet webservice

Oslo, Norway – June 4, 2024NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INOR INTO THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS,ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE"UNITED STATES"), AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGIONOF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN, SOUTH AFRICA OR ANY OTHERJURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFULReference is made to the announcement published by Capsol Technologies ASA (the“Company”) on May 24,

DBP International AB and Vivo Biopharma LLC: Revised Asset Purchase and Collaboration Agreements

Double Bond Pharmaceutical International AB (publ) (“DBP”) and Vivo Biopharma LLC (“Vivo”), today announced an amendment to the Asset Purchase and Collaboration Agreements for DBP’s SI-053 and related assets, originally signed on September 17, 2023.  SI-053 is a locally acting formulation of temozolomide for the treatment of glioblastoma, which received Orphan Drug Designation from the European Medicines Agency in 2016. Recently, SI-053 received both Competent Authority and Ethics Committee approvals to initiate a Phase 1 clinical trial in two Western European countries. The amendment to

AMSC ASA: Notification of trade

Reference is made to the announcement published by Solstad Offshore ASA (the "Company”) on 29 May 2024 regarding the offering of shares (the “Offering”) in Solstad Maritime Holding AS (“SMH”). AMSC ASA has today purchased 2,340,232 subscription rights in the Offering at a price of NOK 9.10 per subscription right. Following the transaction, AMSC ASA owns a total of 2,340,232 subscription rights to shares in SMH. AMSC also owns 84,602,369 shares in SMH.

Cashout Cancellation and Timezone Management: SOFTSWISS Casino Platform Unveils Updates

The SOFTSWISS Casino Platform, an award-winning software for online casinos, releases two bonus features. Cashout cancellation bonus and Timezone management are aimed to influence two vital casino project metrics – engagement and retention.Cashout Cancellation Bonus The Cashout Cancellation Bonus allows players to receive a reward for cancelling their cashout requests. Players can cancel their entire cashout or choose to cancel 25%, 50%, or 75% of it. When a player cancels their cashout and receives the bonus, both the bonus funds and the cashout amount are locked in their account until

TORM plc announces closing of secondary public offering of its class A common shares

TORM plc (the “Company” or “TORM”) (Nasdaq: TRMD or TRMD A) today announces the closing of the previously announced secondary public offering of 6,896,552 of the Company’s Class A common shares by OCM Njord Holdings S.à r.l. (the "Selling Shareholder"), a company indirectly owned by funds managed by Oaktree Capital Management, L.P. and its affiliates. Following the offering, the Selling Shareholder beneficially owns approximately 46.7% of the Company’s Class A common shares. The Company did not sell any Class A common shares and did not receive any proceeds from the offering.

Mandatory notification of trade

Reference is made to the announcement published by Solstad Offshore ASA (the "Company”) on 29 May 2024 regarding the offering of shares (the “Offering”) in Solstad Maritime Holding AS (“SMH”). AMSC ASA has today purchased 2,340,232 subscription rights in the Offering at a price of NOK 9.10 per subscription right. Following the transaction, AMSC ASA owns a total of 2,340,232 subscription rights to shares in SMH. AMSC also owns 84,602,369 shares in SMH. The shares in SMH are linked to Company's shares, cf. the Market Abuse Regulation article 19. AMSC ASA is a person closely

Salmon Evolution ASA: Disclosure of proxies for annual general meeting

Reference is made to the notice of annual general meeting (“AGM”) in Salmon Evolution ASA ("Salmon Evolution" or the "Company", OSE: SALME), to be held on 5 June 2024. The chairperson of the board of directors, Tore Tønseth, has received proxies without voting instructions to vote on behalf of 83,711,307 shares in connection with the AGM. This constitutes approx. 20.2% of the outstanding shares and votes in the Company. Tønseth does not own any shares in the Company. The proxies are only valid for the general meeting on 5 June 2024 (unless they are recalled prior to such time).

AEROF Sweden Bondco AB (publ) calls for a change of the terms of the company’s senior secured bonds and requests certain waivers by initiation of a written procedure

AEROF Sweden Bondco AB (publ) (the "Company" and together with its subsidiaries from time to time, the "Group") has instructed the agent for the Company's senior unsecured bonds with ISIN SE0015483151 (the "Bonds") to initiate a written procedure to request that bondholders vote in favour of certain amendments and waivers to the terms and conditions of the Bonds. The proposed waivers include (i) waiving the equity to bonds outstanding covenant for the reference dates occurring on 31 December 2023 in relation to the audited financial report for the financial year ending on 31 December

The exercise price for warrants of series TO 3 has been set to SEK 0.04 per new share

Carbiotix AB ("Carbiotix" or "the Company") hereby announces that the exercise price for the warrants of series TO 3 (”TO 3”), which were issued in connection with the rights issue of units the Company executed earlier during 2024, has been set. The exercise price for TO 3 has been set to SEK 0.04 per share and the exercise period commences on June 5th, 2024.In January 2024, Carbiotix carried out a rights issue which brought the Company approximately SEK 11.2 million before issue costs. Through the rights issue, 53,163,522 warrants of series TO 3 were issued. Each TO 3 entitles the holder

Relais Group Plc: Share Repurchase 3.6.2024

Relais Group Plc  ANNOUNCEMENT  3.6.2024 Relais Group Plc: Share Repurchase 3.6.2024 In the Helsinki Stock Exchange Trade date           3.6.2024Bourse trade         BuyShare                  RELAISAmount             780 SharesAverage price/ share    12,9000 EURTotal cost            10 062,00 EUR Relais Group Plc now holds a total of 13 529 sharesincluding the shares repurchased on 3.6.2024 On behalf of Relais Group Plc Nordea Bank Oyj Janne Sarvikivi

Environmental application for fish farming in Alby submitted

Big Akwa is making a significant stride forward in its plans to build a large-scale land-based rainbow trout farm near Ljungan in Alby. Today the company submitted its application for environmental permit, marking an important milestone in the project.The planned fish farm is designed to produce 6,000 tons of rainbow trout per year, equivalent to 2-3% of the annual fish consumption in Sweden. This facility will be one of the largest in the country and will utilize state-of-the-art technology, particularly in water purification. Additionally, the fish farm is planned to be situated near the

Do Things You’ve Never Done Before In New Crusader Kings Expansion

Roads to Power Major Expansion Offers New Ways to Play Popular Strategy GameSTOCKHOLM - 03 June 2024 - Learn new ways to unlock power and prestige in Roads to Power, the new Major Expansion from Crusader Kings III. Be a wandering mercenary, building a reputation as a fixer or outlaw, or lead a noble family in an ancient empire, using influence and intrigue to secure your place. New events, government systems, schemes and lifestyles are yours to explore. Coming on September 24, Roads to Power is a major expansion to Crusader Kings III, Paradox Interactive’s award-winning strategy/role-

BerGenBio ASA – Registration of reverse share split

Bergen, Norway, 3 June 2024. Reference is made to the stock exchange announcement made by BerGenBio ASA (the "Company") on 23 May 2024 regarding the Company's annual general meeting resolving a reverse share split of the Company's shares in the ratio 100:1. The reverse share split has today been registered with the Norwegian Register of Business Enterprises. Following such registration, the share capital of the Company is NOK 390,871,160 divided into 39,087,116 shares, each with a nominal value of NOK 10.   For further information, please contact: Martin Olin, CEO, BerGenBio ASA

Evosep Unveils Groundbreaking Innovations in Scalable Proteomics Workflows at ASMS 2024

FOR IMMEDIATE RELEASE Mass Spectrometry  Media Contact Information:Christian Ravnsborg+ 45 26 33 20 21cr@evosep.com    Anaheim, CA – ASMS 2024 - June 3rd, 2024 – Evosep, a leader in the field of proteomics, is proud to announce several significant advancements in scalable proteomics workflows at the ASMS 2024 conference in Anaheim. These innovations underline Evosep's commitment to enhancing the efficiency and accessibility of proteomics as a toolbox, specifically targeting the acceleration of the drug discovery process and bridging translational research to proteomics-

Buy-back of shares in Arise during week 22, 2024

During the period between 27 May and 31 May 2024 Arise AB (publ) (LEI code 549300FOT7EE85QYB655) (“Arise”) repurchased, in total, 103,253 own shares (ISIN code SE0002095604) under the share repurchase program initiated by the Board of Directors to deliver shareholder value and to optimize the capital structure of the company. The share buy-backs form a part of the share repurchase program of a maximum amount of SEK 50 million, which Arise announced on 7 May 2024. The share repurchase program, which runs from 8 May 2024 until the date of Arise's Annual General Meeting in 2025, is being

There are no items matching the current filter
There are no more items matching the current filter
Back to top